3-amino-N-methyl-6-[(2R)-1-[4-(pyrrolidin-1-ylmethyl)benzoyl]piperidin-2-yl]thieno[2,3-b]pyridine-2-carboxamide
C26H31N5O2S — CID 124962732
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-amino-N-methyl-6-[(2R)-1-[4-(pyrrolidin-1-ylmethyl)benzoyl]piperidin-2-yl]thieno[2,3-b]pyridine-2-carboxamide
3-amino-N-methyl-6-[(2R)-1-[4-(pyrrolidin-1-ylmethyl)benzoyl]piperidin-2-yl]thieno[2,3-b]pyridine-2-carboxamide (PubChem CID 124962732) has the molecular formula C26H31N5O2S and a molecular weight of 477.63 g/mol. Its IUPAC name is 3-amino-N-methyl-6-[(2R)-1-[4-(pyrrolidin-1-ylmethyl)benzoyl]piperidin-2-yl]thieno[2,3-b]pyridine-2-carboxamide.
Molecular Properties
| Compound Name | 3-amino-N-methyl-6-[(2R)-1-[4-(pyrrolidin-1-ylmethyl)benzoyl]piperidin-2-yl]thieno[2,3-b]pyridine-2-carboxamide |
|---|---|
| PubChem CID | 124962732 |
| Molecular Formula | C26H31N5O2S |
| Molecular Weight | 477.63 g/mol |
| Exact Mass | 477.22 |
| IUPAC Name | 3-amino-N-methyl-6-[(2R)-1-[4-(pyrrolidin-1-ylmethyl)benzoyl]piperidin-2-yl]thieno[2,3-b]pyridine-2-carboxamide |
| SMILES | CNC(=O)c1sc2nc([C@H]3CCCCN3C(=O)c3ccc(CN4CCCC4)cc3)ccc2c1N |
| InChI | InChI=1S/C26H31N5O2S/c1-28-24(32)23-22(27)19-11-12-20(29-25(19)34-23)21-6-2-3-15-31(21)26(33)18-9-7-17(8-10-18)16-30-13-4-5-14-30/h7-12,21H,2-6,13-16,27H2,1H3,(H,28,32)/t21-/m1/s1 |
| InChIKey | HKZBNGNNALIKLV-OAQYLSRUSA-N |
| XLogP | 4.20 |
| TPSA | 91.56 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 477.63 |
| LogP ≤ 5 | 4.20 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 124962732 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.